 TORONTO, Oct. 31, 2022 GLOBE NEWSWIRE -- Reunion Neuroscience Inc. NASDAQ: REUN, TSX: REUN Reunion or the Company, a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health conditions, announced today that the Company will participate in two upcoming conferences in November. 